â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
  DGAT1 PROTEIN CORRELATION ANALYSIS - CPTAC GBM PROTEOMICS
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Analysis Date: 2025-10-10
Dataset: CPTAC3 GBM Discovery Cohort
Samples: 110 GBM patients
Proteins: 10,804 quantified
Method: Spearman rank correlation with FDR correction

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
KEY FINDINGS
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

FINDING 1: NO SIGNIFICANT IMMUNE CORRELATIONS â—
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

â€¢ 0/24 immune markers showed significant correlation with DGAT1
â€¢ All FDR-adjusted p-values > 0.67
â€¢ Strongest (non-significant): CXCL12 (r=-0.28), CSF1 (r=-0.20)

Interpretation:
â†’ DGAT1 protein does NOT correlate with immune proteins
â†’ Suggests post-transcriptional regulation differs from mRNA
â†’ Immune-DGAT1 relationship may be indirect
â†’ Consider comparing with RNA-seq data


FINDING 2: SIGNIFICANT LIPID METABOLISM CORRELATIONS âœ…
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

1. DGAT1 â†” SREBF1 (SREBP-1): r = +0.336, p_adj = 0.020 âœ…
   â†’ Positive correlation with lipogenesis master regulator
   â†’ Coordinated triglyceride and fatty acid synthesis
   â†’ Supports lipid droplet formation phenotype

2. DGAT1 â†” SREBF2 (SREBP-2): r = -0.354, p_adj = 0.016 âœ…
   â†’ Negative correlation with cholesterol synthesis
   â†’ Metabolic trade-off: TAG synthesis â†‘ Cholesterol â†“
   â†’ GBM cells favor TAG storage when DGAT1 high


FINDING 3: NOTABLE TRENDS (NON-SIGNIFICANT)
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Lipid markers:
â€¢ PLIN3 (lipid droplet): r = +0.18
â€¢ ACSL4 (FA activation): r = +0.23
â€¢ SCAP (SREBP regulation): r = +0.23

Immune markers:
â€¢ CXCL12 (chemokine): r = -0.28
â€¢ CSF1 (M2 recruitment): r = -0.20

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
BIOLOGICAL INTERPRETATION
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

1. PROTEIN-LEVEL DISCONNECT FROM IMMUNE SYSTEM
   â€¢ DGAT1 protein does not correlate with immune proteins
   â€¢ Contrasts with potential mRNA-level relationships
   â€¢ May reflect:
     - Post-transcriptional regulation
     - Protein stability differences
     - Compartmentalization effects
     - Limited detection of immune cell proteins

2. DGAT1 IS PART OF LIPID SYNTHESIS PROGRAM
   â€¢ Strong coordination with SREBP-1 (lipogenesis)
   â€¢ Inverse relationship with SREBP-2 (cholesterol)
   â€¢ Confirms role in triglyceride metabolism pathway

3. METABOLIC REPROGRAMMING IN GBM
   â€¢ High DGAT1 tumors favor TAG synthesis over cholesterol
   â€¢ Supports lipid droplet accumulation phenotype
   â€¢ Consistent with Dr. Guo's lab PLIN/lipid droplet focus

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
MARKERS TESTED
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

IMMUNE MARKERS (24 detected / 41 defined):
Categories:
  âœ… TAM_Pan (100%): CD68, CD14, ITGAM, AIF1
  âœ… Checkpoint_Ligand (100%): CD274, PDCD1LG2, LGALS9, NECTIN2, VSIR
  âœ… MDSC (100%): S100A8, S100A9, ARG1, NOS2
  âš ï¸  TAM_M2 (67%): CD163, MRC1, ARG1, CHI3L1, TGFB1, PTGS2
  âŒ CD8_Effector (0%): All cytokines missing
  âŒ Checkpoint_Receptor (17%): Most missing

LIPID MARKERS (47 detected / 60 defined):
Categories:
  âœ… FA_Uptake (100%): All 9 markers
  âœ… Cholesterol (100%): All 6 markers  
  âœ… Lipolysis (100%): All 4 markers
  âœ… FAO (86%): 6/7 markers
  âœ… Lipogenesis (86%): 6/7 markers
  âœ… Lipid_Droplet (80%): PLIN1-4

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
OUTPUTS GENERATED
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Location: Results/Proteomics/DGAT1_Correlations/

Data Files:
  âœ… DGAT1_Immune_Correlations.csv
  âœ… DGAT1_Lipid_Correlations.csv
  âœ… DGAT1_Analysis_Immune_Genes_Tested.csv
  âœ… DGAT1_Analysis_Lipid_Genes_Tested.csv
  âœ… DGAT1_Analysis_Summary.rds
  âœ… DGAT1_Analysis_sessionInfo.txt

Plots (6 PDFs):
  âœ… 02_DGAT1_Lipid_Correlations_Barplot.pdf
  âœ… 03_DGAT1_Immune_Volcano.pdf
  âœ… 04_DGAT1_Lipid_Volcano.pdf
  âœ… 06_DGAT1_Top_Lipid_Markers_Heatmap.pdf
  âœ… 07_DGAT1_Immune_Category_Summary.pdf
  âœ… 08_DGAT1_Lipid_Category_Summary.pdf

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
STATISTICAL DETAILS
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Method: Spearman rank correlation
Multiple testing: Benjamini-Hochberg FDR
Significance threshold: FDR < 0.05
Minimum sample size: 10 non-NA pairs per comparison

DGAT1 Protein Statistics:
  â€¢ Non-NA samples: 90/110 (81.8%)
  â€¢ Median: 0.124 (log2 ratio)
  â€¢ Range: -0.361 to 1.392
  â€¢ IQR: -0.038 to 0.467

Power Considerations:
  â€¢ Effective n = 90 (limited by missing data)
  â€¢ Proteomics has more missingness than RNA-seq
  â€¢ Immune proteins may be below MS detection
  â€¢ Consider as discovery analysis

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
NEXT STEPS & RECOMMENDATIONS
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

1. COMPARE WITH RNA-SEQ DATA
   â†’ Run same analysis on TCGA/CGGA RNA-seq
   â†’ Check if DGAT1 mRNA correlates with immune genes
   â†’ Identify mRNA-protein discordance

2. FUNCTIONAL VALIDATION
   â†’ DGAT1 inhibition in GBM cell lines
   â†’ Measure lipid droplet formation (PLIN staining)
   â†’ Assess immune marker expression changes
   â†’ Test SREBP-1/2 pathway response

3. MULTI-OMIC INTEGRATION
   â†’ Match CPTAC samples with TCGA (subset overlap)
   â†’ Correlate mRNA-protein for DGAT1, SREBP1, SREBP2
   â†’ Identify post-transcriptionally regulated genes

4. MECHANISTIC STUDIES
   â†’ Test if SREBP-1 drives DGAT1 expression
   â†’ Investigate TAG vs cholesterol metabolic trade-off
   â†’ Examine lipid droplet function in GBM

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
CONCLUSIONS
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

KEY TAKEAWAYS:

1. âœ… DGAT1 protein is part of coordinated lipid synthesis program
2. âœ… Strong evidence for SREBP-1 coordination (lipogenesis)
3. âœ… Inverse relationship with SREBP-2 (cholesterol)
4. â— NO protein-level correlation with immune markers
5. ğŸ”¬ Important to compare with mRNA-level relationships

BIOLOGICAL SIGNIFICANCE:
â†’ DGAT1 in GBM tumors participates in metabolic reprogramming
â†’ Favors triglyceride synthesis over cholesterol synthesis
â†’ Immune relationship (if present) occurs at transcriptional level
â†’ Post-transcriptional regulation may be important

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
END OF SUMMARY
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

